Erdafitinib and enfortumab vedotin in pretreated FGFR2/3-mutant bladder cancer

215 views

VJOncology

2 years ago

Erdafitinib and enfortumab vedotin in pretreated FGFR2/3-mutant bladder cancer

Erdafitinib and enfortumab vedotin in pretreated FGFR2/3-mutant bladder cancer